期刊文献+

慢性肾病糖代谢紊乱患者的血糖控制 被引量:4

Management of glycemia in patients with diabetes mellitus and chronic kidney disease
下载PDF
导出
摘要 糖尿病(DM)是一种全球性疾病,我国DM的发生率也随经济的快速发展而明显升高。目前,不仅糖尿病肾病(DN)成为终末期肾功能衰竭患者最常见的原因之一,其他慢性肾病(CKD)合并DM亦是导致肾功能快速恶化的重要因素。现就晚期DN(Ⅳ~Ⅴ期)及Ⅲ期以上CKD伴代谢紊乱的患者如何合理有效地控制血糖进行综述。 Diabetes mellitus(DM) is a leading cause of chronic kidney disease(CKD) worldwide,and its rising prevalence may explain much of the increase in the incidence of kidney failure.Even when DM is not the cause of kidney disease,the coexistence of CKD and DM presents unique problems that need to be recognized and managed appropriately to optimize the outcomes.The objective of this article is to outline the management of glycemia in patients with DM of stage Ⅳ-Ⅴ and CKD ≥ stage Ⅲ,followed by a review of the appropriate use of available hypoglycemic agents for such patients,with an emphasis on the newer classes of the agents.
出处 《医学研究生学报》 CAS 2008年第10期1113-1117,共5页 Journal of Medical Postgraduates
关键词 糖尿病 糖尿病肾病 慢性肾病 血糖控制 Diabetes mellitus Diabetic nephropathy Chronic kidney disease Control of blood glucose
  • 相关文献

参考文献20

  • 1Muggeo M, Bolli G, Bompiani G, et al. Glycemic control and cardiovascular diseases in Type 2 diabetes mellitus. Beyond fasting glycemia and glycosylated hemoglobin [ J ]. Diabetes Nutr Metab ,2000,13 (4) : 182-185.
  • 2Crook ED, Patel S. Glycemic control predicts diabetic extrarenal microvascular complications but not renal survival in patients with moderate to severe chronic kidney disease [ J ]. Ethn Dis,2006, 16(4) :865-871.
  • 3Lubowsky ND, Siegel R, Pittas AG. Management of glycemia in patients with diabetes mellitus and CKD[J]. Am J Kidney Dis, 2007, 50(5) : 865-879.
  • 4Okada T, Nakao T, Matsumoto H, et al. Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease [J]. Intern Med, 2007, 46(12) :807-814.
  • 5Sechi LA, Catena C, Zingaro L, et al. Abnormalities of glucose metabolism in patients with early renal failure [ J ]. Diabetes, 2002, 51(4) : 1226-1232.
  • 6Little RR, Tennill AL, Rohlfing C, et al. Can glycohemoglobin be used to assess glycemic control in patients with chronic renal failure? [J] Clin Chem, 2002, 48(5) : 784-786.
  • 7Krepinsky J, Ingram A J, Clase CM. Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with endstage renal disease[J]. Am J Kidney Dis,2000,35(3) :500-505.
  • 8Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes : a consensus algorithm for the initiation and adjustment of therapy : a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes [ J ]. Diabetes Care, 2006,29 ( 8 ) : 1963- 1972.
  • 9Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes [ J ]. N Engl J Med, 2007, 356(24) : 2457-2471.
  • 10Home PD, Pocock SJ, Beck-Nielsen H, et al. Rosiglitazone evaluated, for cardiovascular outcomes-an interim analysis [ J ]. N Engl J Med,2007,357( 1 ) :28-38.

二级参考文献54

  • 1孙晓健,侯晓菲,刘少荣,刘文波,陶志刚,李建远.醛固酮合成酶基因-344T/C多态性与山东省汉族人原发性高血压相关性[J].中华医学遗传学杂志,2004,21(5):502-504. 被引量:33
  • 2夏正坤,祁建胜,刘光陵.血管紧张素Ⅱ受体拮抗剂在IgA肾病中的临床应用[J].医学研究生学报,2005,18(5):451-453. 被引量:5
  • 3狄红杰,赵明,王扬天.糖尿病大鼠视网膜病变核因子-κB表达水平的研究[J].医学研究生学报,2006,19(4):341-343. 被引量:8
  • 4王扬天,赵明,狄红杰.糖尿病大鼠肾病变过程中核因子-κB及诱导型一氧化氮合酶的表达[J].医学研究生学报,2006,19(5):416-419. 被引量:6
  • 5Takebayashi K,Matsumoto S,Aso Y,et al.Aldosterone blockadc attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy[J].J Clin Endocrinol Metab,2006,91 (6):2214-2217.
  • 6Cha DR,Kang YS,Han SY,et al.Role of aldosterone in diabetic nephropathy[J].Nephrology,2005,10(Suppl):S37-39.
  • 7Delyani JA.Mineralocorticoid receptor antagonists:The evolution of utility and pharmacology[J].Kidney Int,2000,57(4):1408-1411.
  • 8Pitt B,Zannad F,Remme WJ,et al.for the Randomized Aldactone Evaluation Study:The effect of spironolactone on morbidity and mortality in patients with severe heart failure[J].N Engl J Med,1999,341 (10):709-717.
  • 9Pitt B,Remme W,Zannad F,et al.For the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators:Eplerenone,a selective aldosterone blocker,in patients with left ventricular dysfunction after myocardial infarction[J].N Engl J Med,2003,348(14):1309-1321.
  • 10Smith SC Jr,Allen J,Blair SN,et al.AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease:2006 update:endorsed by the National Heart,Lung,and Blood Institute[J].Circulation,2006,113(19):2363-2372.

共引文献27

同被引文献88

  • 1Mazzali M,Kanellis J,Han L,et al.Hyperuricemia induces a primary arteriolopathy in rats by a blood pressure-independent mechanism[J].Am J Phyiol Renal Physiol,2002,282(7):991-997.
  • 2Ohnaka K,Numaguchi K,Yamakawa T,et al.Induction of cyclooxygenase-2 by angiotension Ⅱ in cultured rat vascular smooth muscle cells[J].Hypertension,2000,35(1):68-75.
  • 3Johnson RJ,Feig DI,Nakagawa T,et al.Pathogenesis of essential hypertension:Historical paradigms and modern insights[J].J Hypertens,2008,26(4):381-391.
  • 4Feig DI,Kang DH,Nakagawa T,et al.Uric acid and hypertension[J].Curr Hypertens Rep,2006,8(2):111-115.
  • 5Feig DI,Soletsky B,Johnson RJ.Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension:A randomized trial[J].JAMA,2008,300(8):924-932.
  • 6Feig DI,Kang DH,Johnson RJ.Uric acid and cadiovascular risk[J].N Ehgl J Med,2008,359(13):1811-1821.
  • 7Johnson RJ,Perez-Pozo SE,Sautin YY,et al.Hypothesis:Could excessive fructose intake and uric acid cause type 2 diabetes?[J] Endocr Rev,2009,30(1):96-116.
  • 8Wu X,Wakamiya M,Vaishnav S,et al.Hyperuricemia and urate nephropathy in urate oxidase-deficient mice[J].Proc Natl Acad Sci USA,1994,91(6):742-746.
  • 9Sanchez-Lozada LG,Apia ES,Jherrera-Acosta J.Mild hyperuricemia increases arteiolopathy inducing renal cortical ischemia in 5/6 nephrectomy rats[J].J Am Soc Nephrol,2003,13(12):2888-2897.
  • 10Mazzali M,Hughes J,Kim YG,et al.Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism[J].Hypertension,2001,38(5):1101-1106.

引证文献4

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部